Evogene Ltd. — Form SCHEDULE 13D/A
Filed August 28, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
▼ Likely negative
significance 42/100
What the filing says
L.I.A. Pure Capital and Invest-Pro, disclosed shareholders in Evogene Ltd., issued an August 28, 2026 response criticizing the incumbent board's track record of underperformance and shareholder value erosion despite years of promised value creation and technology investments. The activists are soliciting shareholder votes for their own nominees at the upcoming annual meeting, arguing that board refreshment should be measured by results, not experience or recent additions.
Why this rating
Proxy contest signals internal governance dispute and shareholder dissatisfaction; magnitude unclear without disclosure of stake size, company market cap, or financial metrics.
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.